H&R GmbH & Co KGaA
Company Profile
Business description
H&R GmbH & Co KGaA is a manufacturer of chemical-pharmaceutical specialty products. The company organizes its operating activities into two business divisions: Chemical-Pharmaceutical Raw Materials and Plastics. It also has three business segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment produces specialty products from crude oil in the two domestic refineries (Hamburg-Neuhof and Salzbergen). Its ChemPharm Sales segment encompasses the production sites abroad as well as international sales activities. The company's Plastics segment manufactures high-precision plastic parts along with the associated tools and molds. The company derives a majority of its revenue from the ChemPharm Refining segment. Geographically, it derives key revenue from Germany.
Contact
Neuenkirchener Strasse 8
SalzbergenNI48499
DEUT: +49 59769450
Sector
Basic Materials
Stock type
Cyclical
Industry
Specialty Chemicals
Fiscal Year End
31 December 2026
Employees
1,719
Stocks News & Analysis
stocks
Chart of the Week: Inflation fears dampen sentiment on retailers
stocks
Here’s 3 Top Rated ASX shares for 2026
stocks
Undervalued Aussie e-commerce winner
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,046.50 | 22.30 | 0.25% |
| CAC 40 | 8,230.09 | 3.83 | -0.05% |
| DAX 40 | 25,213.64 | 91.38 | 0.36% |
| Dow JONES (US) | 48,996.08 | 466.00 | -0.94% |
| FTSE 100 | 10,031.17 | 17.04 | -0.17% |
| HKSE | 26,149.31 | 309.64 | -1.17% |
| NASDAQ | 23,584.28 | 37.10 | 0.16% |
| Nikkei 225 | 51,117.26 | 844.72 | -1.63% |
| NZX 50 Index | 13,716.86 | 1.84 | 0.01% |
| S&P 500 | 6,920.93 | 23.89 | -0.34% |
| S&P/ASX 200 | 8,720.80 | 18.20 | 0.21% |
| SSE Composite Index | 4,082.98 | 2.79 | -0.07% |